최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Acs applied polymer materials, v.3 no.11, 2021년, pp.5982 - 5998
Kim, So-Yeon (Therapeutics & Biotechnology Division , Korea Research Institute of Chemical Technology , Daejeon 34114 , Republic of Korea) , Yoon, Ji Young (Bioconvergence Analysis , Korea Basic Science Institute , Cheongju-si 28119 , Republic of Korea) , Lee, Haesoo (College of Pharmacy , Chungnam National University , Daejeon 34134 , Republic of Korea) , Cho, Cheong-Weon (College of Pharmacy , Chungnam National University , Daejeon 34134 , Republic of Korea) , Seong, Hasoo
Tumor microenvironment-sensitive nanoliposomes (TMS-NLs) were prepared as triple negative breast cancer (TNBC)-specific carriers for synergistic therapeutics. The NLs shed polyethylene glycol (PEG) by matrix metalloproteinase 9 (MMP9) secreted from the cancer cells, expose a cell-penetrating peptide...
Karaayvaz, Mihriban, Cristea, Simona, Gillespie, Shawn M., Patel, Anoop P., Mylvaganam, Ravindra, Luo, Christina C., Specht, Michelle C., Bernstein, Bradley E., Michor, Franziska, Ellisen, Leif W.. Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq. Nature communications, vol.9, no.1, 3588-.
Boichuk, Sergei, Galembikova, Aigul, Sitenkov, Alexandr, Khusnutdinov, Ramil, Dunaev, Pavel, Valeeva, Elena, Usolova, Natalia. Establishment and characterization of a triple negative basal-like breast cancer cell line with multi-drug resistance. Oncology letters, vol.14, no.4, 5039-5045.
Shi, Zhi, Peng, Xing-Xiang, Kim, In-Wha, Shukla, Suneet, Si, Qiu-Sheng, Robey, Robert W., Bates, Susan E., Shen, Tong, Ashby Jr., Charles R., Fu, Li-Wu, Ambudkar, Suresh V., Chen, Zhe-Sheng. Erlotinib (Tarceva, OSI-774) Antagonizes ATP-Binding Cassette Subfamily B Member 1 and ATP-Binding Cassette Subfamily G Member 2-Mediated Drug Resistance. Cancer research : the official organ of the American Association for Cancer Research, Inc, vol.67, no.22, 11012-11020.
Zhang, Wei, Fan, Ying-Fang, Cai, Chao-Yun, Wang, Jing-Quan, Teng, Qiu-Xu, Lei, Zi-Ning, Zeng, Leli, Gupta, Pranav, Chen, Zhe-Sheng. Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells. Frontiers in pharmacology, vol.9, 1097-.
Reeves, Patrick M., Abbaslou, Mojgan A., Kools, Farah R.W., Vutipongsatorn, Kritchai, Tong, Xiaoyun, Gavegano, Christina, Schinazi, Raymond F., Poznansky, Mark C.. Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice. Oncotarget, vol.8, no.55, 94040-94053.
Ubezio, Paolo, Falcetta, Francesca, Carrassa, Laura, Lupi, Monica. Integrated experimental and simulation study of the response to sequential treatment with erlotinib and gemcitabine in pancreatic cancer. Oncotarget, vol.7, no.13, 15492-15506.
Wang, Hanlu, Qin, Meng, Liu, Rihe, Ding, Xinxin, Chen, Irvin S. Y., Jiang, Yongping. Characterization of A Bifunctional Synthetic RNA Aptamer and A Truncated Form for Ability to Inhibit Growth of Non-Small Cell Lung Cancer. Scientific reports, vol.9, no.1, 18836-.
Al-Lazikani, Bissan, Banerji, Udai, Workman, Paul. Combinatorial drug therapy for cancer in the post-genomic era. Nature biotechnology, vol.30, no.7, 679-692.
Lee, Michael J., Ye, Albert S., Gardino, Alexandra K., Heijink, A., Sorger, Peter K., MacBeath, G., Yaffe, Michael B.. Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks. Cell, vol.149, no.4, 780-794.
Meng, Fanfei, Han, Ning, Yeo, Yoon. Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy. Expert opinion on drug delivery, vol.14, no.3, 427-446.
Sci. Signaling Morton S. M. ra44 7 2014 10.1126/scisignal.2005261
Zhou, Zilan, Jafari, Mina, Sriram, Vishnu, Kim, Jinsoo, Lee, Joo-Youp, Ruiz-Torres, Sasha J., Waltz, Susan E.. Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy. Molecular pharmaceutics, vol.14, no.12, 4551-4559.
Robertson, Neil M., Yang, Khan, Irfan, LaMantia, Vincent E., Royzen, Maksim, Yigit, Mehmet V.. Single-trigger dual-responsive nanoparticles for controllable and sequential prodrug activation. Nanoscale, vol.9, no.28, 10020-10030.
Feng, Yanlin, Cheng, Yan, Chang, Yun, Jian, Hui, Zheng, Runxiao, Wu, Xiaqing, Xu, Keqiang, Wang, Li, Ma, Xiaomin, Li, Xi, Zhang, Haiyuan. Time-staggered delivery of erlotinib and doxorubicin by gold nanocages with two smart polymers for reprogrammable release and synergistic with photothermal therapy. Biomaterials, vol.217, 119327-.
Dai, Wenbing, Jin, Wu, Zhang, Junlin, Wang, Xueqing, Wang, Jiancheng, Zhang, Xuan, Wan, You, Zhang, Qiang. Spatiotemporally Controlled Co-delivery of Anti-vasculature Agent and Cytotoxic Drug by Octreotide-Modified Stealth Liposomes. Pharmaceutical research, vol.29, no.10, 2902-2911.
Nam, Jae Hyun, Kim, So-Yeon, Seong, Hasoo. Investigation on Physicochemical Characteristics of a Nanoliposome-Based System for Dual Drug Delivery. Nanoscale research letters, vol.13, no.1, 101-.
Muppidi, Krishna, Wang, Jeffrey, Betageri, Guru, Pumerantz, Andrew S.. PEGylated Liposome Encapsulation Increases the Lung Tissue Concentration of Vancomycin. Antimicrobial agents and chemotherapy, vol.55, no.10, 4537-4542.
Monteiro, Liziane O.F., Fernandes, Renata S., Oda, Caroline M.R., Lopes, Sávia C., Townsend, Danyelle M., Cardoso, Valbert N., Oliveira, Mônica C., Leite, Elaine A., Rubello, Domenico, de Barros, André L.B.. Paclitaxel-loaded folate-coated long circulating and pH-sensitive liposomes as a potential drug delivery system: A biodistribution study. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie, vol.97, 489-495.
Romberg, Birgit, Hennink, Wim E., Storm, Gert. Sheddable Coatings for Long-Circulating Nanoparticles. Pharmaceutical research, vol.25, no.1, 55-71.
Fang, Yan, Xue, Jianxiu, Gao, Shan, Lu, Anqi, Yang, Dongjuan, Jiang, Hong, He, Yang, Shi, Kai. Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery. Drug delivery, vol.24, no.1, 22-32.
Sun, Jiawei, Jiang, Lei, Lin, Yi, Gerhard, Ethan Michael, Jiang, Xuehua, Li, Li, Yang, Jian, Gu, Zhongwei. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides. International journal of nanomedicine, vol.12, 1517-1537.
Liang, Hongge, Liu, Xiaoyan, Wang, Mengzhao. Immunotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer treatment. OncoTargets and therapy, vol.11, 6189-6196.
Steinbach, J.M., Seo, Y.E., Saltzman, W.M.. Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization. Acta Biomaterialia: structure-property-function relationships in biomaterials, vol.30, 49-61.
Zhang, Dongdong, Wang, Jiaxi, Xu, Donggang. Cell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systems. Journal of controlled release : official journal of the Controlled Release Society, vol.229, 130-139.
Montrose, Kristopher, Yang, Yi, Sun, Xueying, Wiles, Siouxsie, Krissansen, Geoffrey W.. Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs. Scientific reports, vol.3, 1661-.
Sci. Rep. Montrose K. 4900 4 2014 10.1038/srep04900
Veiman, K.L., Kunnapuu, K., Lehto, T., Kiisholts, K., Parn, K., Langel, U., Kurrikoff, K.. PEG shielded MMP sensitive CPPs for efficient and tumor specific gene delivery in vivo. Journal of controlled release : official journal of the Controlled Release Society, vol.209, 238-247.
Wang, H.X., Yang, X.Z., Sun, C.Y., Mao, C.Q., Zhu, Y.H., Wang, J.. Matrix metalloproteinase 2-responsive micelle for siRNA delivery. Biomaterials, vol.35, no.26, 7622-7634.
Pavlova, Natalya N., Thompson, Craig B.. The Emerging Hallmarks of Cancer Metabolism. Cell metabolism, vol.23, no.1, 27-47.
Brunetti, Jlenia, Riolo, Giulia, Depau, Lorenzo, Mandarini, Elisabetta, Bernini, Andrea, Karousou, Evgenia, Passi, Alberto, Pini, Alessandro, Bracci, Luisa, Falciani, Chiara. Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity. Frontiers in oncology, vol.9, 843-.
Köhrmann, Andrea, Kammerer, Ulrike, Kapp, Michaela, Dietl, Johannes, Anacker, Jelena. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature. BMC cancer, vol.9, 188-188.
Mehner, Christine, Hockla, Alexandra, Miller, Erin, Ran, Sophia, Radisky, Derek C., Radisky, Evette S.. Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer. Oncotarget, vol.5, no.9, 2736-2749.
Chou, Ting-Chao. Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method. Cancer research : the official organ of the American Association for Cancer Research, Inc, vol.70, no.2, 440-446.
Yamasaki, Fumiyuki, Zhang, Dongwei, Bartholomeusz, Chandra, Sudo, Tamotsu, Hortobagyi, Gabriel N., Kurisu, Kaoru, Ueno, Naoto T.. Sensitivity of breast cancer cells to erlotinib depends on cyclin-dependent kinase 2 activity. Molecular cancer therapeutics, vol.6, no.8, 2168-2177.
Shen, Zhiqiang, Ye, Huilin, Kröger, Martin, Li, Ying. Aggregation of polyethylene glycol polymers suppresses receptor-mediated endocytosis of PEGylated liposomes. Nanoscale, vol.10, no.9, 4545-4560.
Malavaki, Christina J., Roussidis, Andreas E., Gialeli, Chrisostomi, Kletsas, Dimitris, Tsegenidis, Theodore, Theocharis, Achileas D., Tzanakakis, George N., Karamanos, Nikos K.. Imatinib as a key inhibitor of the platelet‐derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells. The FEBS journal, vol.280, no.10, 2477-2489.
Matsuo, Hirotami, Chevallier, Julien, Mayran, Nathalie, Le Blanc, Isabelle, Ferguson, Charles, Fauré, Julien, Blanc, Nathalie Sartori, Matile, Stefan, Dubochet, Jacques, Sadoul, Rémy, Parton, Robert G., Vilbois, Francis, Gruenberg, Jean. Role of LBPA and Alix in Multivesicular Liposome Formation and Endosome Organization. Science, vol.303, no.5657, 531-534.
Yang, Sung-Tae, Zaitseva, Elena, Chernomordik, Leonid V., Melikov, Kamran. Cell-Penetrating Peptide Induces Leaky Fusion of Liposomes Containing Late Endosome-Specific Anionic Lipid. Biophysical journal, vol.99, no.8, 2525-2533.
Erazo-Oliveras, Alfredo, Muthukrishnan, Nandhini, Baker, Ryan, Wang, Ting-Yi, Pellois, Jean-Philippe. Improving the Endosomal Escape of Cell-Penetrating Peptides and Their Cargos: Strategies and Challenges. Pharmaceuticals, vol.5, no.11, 1177-1209.
Erazo-Oliveras, A., Najjar, K., Truong, D., Wang, T.Y., Brock, Dakota J., Prater, Austin R., Pellois, J.P.. The Late Endosome and Its Lipid BMP Act as Gateways for Efficient Cytosolic Access of the Delivery Agent dfTAT and Its Macromolecular Cargos. Cell chemical biology, vol.23, no.5, 598-607.
Lönn, Peter, Kacsinta, Apollo D., Cui, Xian-Shu, Hamil, Alexander S., Kaulich, Manuel, Gogoi, Khirud, Dowdy, Steven F.. Enhancing Endosomal Escape for Intracellular Delivery of Macromolecular Biologic Therapeutics. Scientific reports, vol.6, 32301-.
Najjar, Kristina, Erazo-Oliveras, Alfredo, Mosior, John W., Whitlock, Megan J., Rostane, Ikram, Cinclair, Joseph M., Pellois, Jean-Philippe. Unlocking Endosomal Entrapment with Supercharged Arginine-Rich Peptides. Bioconjugate chemistry, vol.28, no.12, 2932-2941.
Coutinho, Frazer P., Green, Colin R., Rupenthal, Ilva D.. Intracellular oligonucleotide delivery using the cell penetrating peptide Xentry. Scientific reports, vol.8, 11256-.
KWON, YUN-SUK, CHUN, SO-YOUNG, NAM, KYUNG-SOO, KIM, SOYOUNG. Lapatinib sensitizes quiescent MDA-MB-231 breast cancer cells to doxorubicin by inhibiting the expression of multidrug resistance-associated protein-1. Oncology reports, vol.34, no.2, 884-890.
Manupati, Kanakaraju, Dhoke, Neha R., Debnath, Tanusree, Yeeravalli, Ragini, Guguloth, Kalpana, Saeidpour, Shahrzad, De, Utpal Chandra, Debnath, Sudhan, Das, Amitava. Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal–epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs. The FEBS journal, vol.284, no.12, 1830-1854.
Breast Cancer: Basic Clin. Res. Subik K. 35 4 2010
Necela, Brian M., Crozier, Jennifer A., Andorfer, Cathy A., Lewis-Tuffin, Laura, Kachergus, Jennifer M., Geiger, Xochiquetzal J., Kalari, Krishna R., Serie, Daniel J., Sun, Zhifu, Moreno-Aspitia, Alvaro, O’Shannessy, Daniel J., Maltzman, Julia D., McCullough, Ann E., Pockaj, Barbara A., Cunliffe, Heather E., Ballman, Karla V., Thompson, E. Aubrey, Perez, Edith A.. Correction: Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors. PloS one, vol.10, no.4, e0127133-.
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.